Department of Community Medicine, National Institute of Preventive and Social Medicine (NIPSOM), Dhaka, Bangladesh.
Department of Public Health and Hospital Administration, National Institute of Preventive and Social Medicine (NIPSOM), Dhaka, Bangladesh.
PLoS One. 2023 Feb 22;18(2):e0279032. doi: 10.1371/journal.pone.0279032. eCollection 2023.
The coronavirus disease 2019 (COVID-19) stances an incredible impact on the quality of life and denigrates the physical and mental health of the patients. This cross-sectional study aimed to assess the health-related quality of life (HRQOL) of COVID-19 patients. We conducted this study at the National Institute of Preventive and Social Medicine (NIPSOM) of Bangladesh for the period of June to November 2020. All the COVID-19 patients diagnosed by real-time reverse transcriptase-polymerase chain reaction (RT-PCR) assay in July 2020 formed the sampling frame. The study enrolled 1204 adult (aged >18 years) COVID-19 patients who completed a one-month duration of illness after being RT-PCR positive. The patients were interviewed with the CDC HRQOL-14 questionnaire to assess HRQOL. Data were collected by telephone interview on the 31st day of being diagnosed and by reviewing medical records using a semi-structured questionnaire and checklist. Around two-thirds (72.3%) of the COVID-19 patients were males and a half (50.2%) were urban residents. In 29.8% of patients, the general health condition was not good. The mean (±SD) duration of physical illness and mental illness was 9.83(±7.09) and 7.97(±8.12) days, respectively. Most of the patients (87.0%) required help with personal care, and 47.8% required assistance with routine needs. The mean duration of 'healthy days' and 'feeling very healthy' was significantly lower in patients with increasing age, symptoms, and comorbidity. The mean duration of 'usual activity limitation', 'health-related limited activity', 'feeling pain/worried', and 'not getting enough rest' were significantly higher among patients' having symptoms and comorbidity. 'Not so good' health condition was significantly higher in females (OR = 1.565, CI = 1.01-2.42) and those having a symptom (OR = 32.871, CI = 8.06-134.0) of COVID-19 and comorbidity (OR = 1.700, CI = 1.26-2.29). Mental distress was significantly higher among females (OR = 1.593, CI = 1.03-2.46) and those having a symptom (OR = 4.887, CI = 2.58-9.24). Special attention should be given to COVID-19 patients having symptoms and comorbidity to restore their general health, quality of life, and daily activities.
2019 年冠状病毒病（COVID-19）对患者的生活质量产生了巨大影响，并损害了他们的身心健康。本横断面研究旨在评估 COVID-19 患者的健康相关生活质量（HRQOL）。本研究在孟加拉国国家预防和社会医学研究所（NIPSOM）进行，时间为 2020 年 6 月至 11 月。2020 年 7 月，通过实时逆转录-聚合酶链反应（RT-PCR）检测确诊的所有 COVID-19 患者均构成抽样框架。该研究纳入了 1204 名年龄在 18 岁以上的成年 COVID-19 患者，他们在 RT-PCR 阳性后经历了为期一个月的病程。通过 CDC HRQOL-14 问卷对患者进行访谈，以评估 HRQOL。在诊断后的第 31 天通过电话访谈收集数据，并使用半结构式问卷和检查表查阅病历。大约三分之二（72.3%）的 COVID-19 患者为男性，一半（50.2%）为城市居民。在 29.8%的患者中，一般健康状况不佳。躯体疾病和精神疾病的平均（±SD）持续时间分别为 9.83（±7.09）和 7.97（±8.12）天。大多数患者（87.0%）需要他人帮助进行个人护理，47.8%需要帮助满足日常需求。随着年龄、症状和合并症的增加，患者“健康日”和“感觉非常健康”的平均持续时间显著降低。在有症状和合并症的患者中，“日常活动受限”、“与健康相关的活动受限”、“感到疼痛/担忧”和“得不到足够休息”的平均持续时间显著升高。女性（OR=1.565，CI=1.01-2.42）和有症状（OR=32.871，CI=8.06-134.0）和合并症（OR=1.700，CI=1.26-2.29）的患者健康状况不佳的比例显著更高。女性（OR=1.593，CI=1.03-2.46）和有症状（OR=4.887，CI=2.58-9.24）的患者精神困扰显著更高。应特别关注有症状和合并症的 COVID-19 患者，以恢复其总体健康、生活质量和日常活动能力。
